ModelEdge

Transcode Therapeutics Inc.
RNAZ
Filing Type8-K
Filing Date10/7/2025
Updated10/8/25, 7:57 AM

Filing

8-K
Earnings Release

Exhibits

8-KMaterial Contracts, Completing Asset Acquisition or Sale, Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Reg. FD
EX-2.1EXHIBIT 2.1
EX-3.1EXHIBIT 3.1
EX-4.1EXHIBIT 4.1
EX-10.1EXHIBIT 10.1
EX-10.2EXHIBIT 10.2
EX-99.1Material Contracts, Completing Asset Acquisition or Sale, Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Reg. FD
EX-99.2Material Contracts, Completing Asset Acquisition or Sale, Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Reg. FD
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic